中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月12日星期六
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2022, Vol. 29 Issue (13): 103-105转109    
  放射与影像 本期目录 | 过刊浏览 | 高级检索 |
冠状动脉CT血管造影血管斑块特点与狭窄情况预测心肌缺血的效能
赵 辉 张吉权
湖北省咸宁市第一人民医院放射科,湖北咸宁437000
Efficacy of coronary CT angiography plaque characteristics and stenosis in predicting myocardial ischemia
ZHAO Hui ZHANG Jiquan
Department of Radiology, Xianning First People′s Hospital, Hubei Province, Xianning 437000, China
全文: PDF (705 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探究冠状动脉CT 血管造影(CCTA)血管斑块特点与狭窄情况预测心肌缺血的效能。 方法 选取2019年1月至2020年12月咸宁市第一人民医院接收疑诊或已知的冠心病患者88 例(病变血管196 支)作为研究对象,入选患者在入院后均接受CCTA、冠状动脉造影(CAG)与血流储备分数(FFR)检查,金标准为心肌FFR 测定值,根据FFR 值分为缺血组(n=45,99 支病变血管,FFR 值≥0.8)与非缺血组(n=43,97 支病变血管,FFR 值<0.8)。 回顾性分析两组患者临床基线资料,比较两组患者CCTA 血管斑块特点、血管狭窄情况,分析CCTA 血管斑块特点、血管狭窄率诊断心肌缺血的价值。结果 缺血组病变血管狭窄程度重于非缺血组,差异有统计学意义(P<0.05)。检查结果显示,缺血组病变血管斑块负荷、斑块体积、钙化积分高于非缺血组,病变长度低于非缺血组,CT 高危斑块、低密度斑块多于非缺血组,差异有统计学意义(P<0.05);ROC 分析显示,CCTA 病变血管狭窄率(>75%狭窄)、CT 高危斑块、病变长度、联合检测预测心肌缺血的AUC 分别为0.626、0.605、0.696、0.759。 结论 CCTA 血管斑块特点、血管狭窄率预测患者心肌缺血的效能良好,两者联合可作为心肌缺血的重要诊断指标。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 冠状动脉CT 血管造影血管斑块血管狭窄心肌缺血预测效能    
Abstract:Objective To investigate the efficacy of coronary CT angiography (CCTA) in predicting myocardial ischemia with Coronary plaque characteristics and stenosis. Methods From January 2019 to December 2020, 88 patients with suspected or known coronary heart disease (196 diseased vessels) admitted to Xianning First People′s Hospital were selected as the study subjects. After admission, all the enrolled patients received CCTA, coronary artery angiography(CAG)and Fractional flow reserve(FFR)examination,and the gold standard was the cardiac FFR value.According to FFR value, they were divided into ischemic group (n=45, 99 vessels with lesion, FFR value ≥0.8) and non-ischemic group(n=43, 97 vessels with lesion, FFR value <0.8). The clinical baseline data of the two groups were retrospectively analyzed, and the characteristics of CCTA plaque and the stenosis of the two groups were compared. The value of THE characteristics of CCTA plaque and the stenosis rate in the diagnosis of myocardial ischemia were analyzed. Results The degree of stenosis in the ischemic group was more severe than that in the non-ischemic group, and the difference was statistically significant (P<0.05). The results showed that the vascular plaque load, plaque volume and calcification score in the ischemic group were higher than those in the non-ischemic group, and the lesion length was lower than that in the non-ischemic group, with statistical significances (P<0.05). CT high-risk plaque and low-density plaque were more than those in the non-ischemic group, with statistical significances (P<0.05). ROC analysis showed that the AUC of CCTA lesion stenosis rate (>75% stenosis), CT high-risk plaque, lesion length and combined detection in predicting myocardial ischemia were 0.626, 0.605, 0.696 and 0.759, respectively. Conclusion CCTA has good efficacy in predicting myocardial ischemia in patients with vascular plaque characteristics and vascular stenosis rate, and the combination of CCTA and CCTA can be used as an important diagnostic index of myocardial ischemia.
Key wordsCoronary CT angiography    Vascular plaque    Vascular stenosis    Myocardial ischemia    Prediction
    
引用本文:   
赵辉; 张吉权. 冠状动脉CT血管造影血管斑块特点与狭窄情况预测心肌缺血的效能[J]. 中国当代医药, 2022, 29(13): 103-105转109.
ZHAO Hui ZHANG Jiquan. Efficacy of coronary CT angiography plaque characteristics and stenosis in predicting myocardial ischemia. 中国当代医药, 2022, 29(13): 103-105转109.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2022/V29/I13/103
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载